SURAKSHA DIAGNOSTIC
Back to Cashflow Statement
|
SURAKSHA DIAGNOSTIC Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-35 Cr | ₹-21 Cr | ₹-44 Cr | ₹-28 Cr | ₹-20 Cr |
What is the latest Cash Flow from Investing Activities ratio of SURAKSHA DIAGNOSTIC ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-35 Cr |
Mar2023 | ₹-21 Cr |
Mar2022 | ₹-44 Cr |
Mar2021 | ₹-28 Cr |
Mar2020 | ₹-20 Cr |
How is Cash Flow from Investing Activities of SURAKSHA DIAGNOSTIC Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-35 Cr | Negative | |
Mar2023 | ₹-21 Cr | Negative | |
Mar2022 | ₹-44 Cr | Negative | |
Mar2021 | ₹-28 Cr | Negative | |
Mar2020 | ₹-20 Cr | - |
Compare Cash Flow from Investing Activities of peers of SURAKSHA DIAGNOSTIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SURAKSHA DIAGNOSTIC | ₹1,631.0 Cr | -3.5% | -5.6% | NA | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹118,495.0 Cr | -3.7% | 2.2% | 32.5% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹104,184.0 Cr | -1.4% | 3.5% | 13.6% | Stock Analytics | |
FORTIS HEALTHCARE | ₹61,102.5 Cr | 1.7% | 7.3% | 66.9% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹40,588.1 Cr | 1.8% | 0% | 54.4% | Stock Analytics | |
GLOBAL HEALTH | ₹34,682.1 Cr | -3.6% | 11.4% | 8.1% | Stock Analytics |
SURAKSHA DIAGNOSTIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SURAKSHA DIAGNOSTIC | -3.5% |
-5.6% |
|
SENSEX | -0.5% |
-0.3% |
1% |
You may also like the below Video Courses